Latest Updates
-
Chana Masala Recipe: Experience Dhaba Style Authentic Taste -
Struggling With Oily Skin This Summer? Simple Tips to Keep Shine Under Control -
Garlic Bread Recipe: The Cheesy Bakery Style Trick You Need -
Soha Ali Khan Swears By This ‘Gentle Game-Changer’ Lemon Drink for Gut Health: Full Recipe Inside -
World Health Day 2026: You’re Not As Healthy As You Think—Here’s Why -
One Pot Easy Lunch Recipe: Flavorful Veg Pulao -
Karan Aujla India Tour Controversy: Lucknow and Ludhiana Shows Cancelled—What Went Wrong? -
Kissing Disease Linked to 3x Higher Risk of Multiple Sclerosis: What You Should Know -
Feeling Drained in the Heat? 10 Healthy Drinks to Sip This Summer -
Happy Birthday Rashmika Mandanna: Steal Her White Looks For Easter 2026 Festive Parties And Celebrations
Combination Of Drugs To Terminate Prostate Cancer
London : Scientists found that two drugs used to treat cholesterol and arthritis can halt the progress of prostate cancer.
A combination of Celebrex, an anti-inflammatory drug, and the statin Lipitor kept the cancer in its less aggressive early stage in tests on mice.
Dr Allan Conney of Rutgers University in New Jersey, which carried out the research, said, "This is something we hope is going to save lives. If clinical trials go well, we could have something available in five years." "If the trials show that the drug therapy does a good job of preventing the cancer from advancing, we won't need to worry about how to handle the more aggressive later stage cancer," he added.
Professor Xi Zheng said low doses of Lipitor and Celebrex had a "potent inhibiting effect on the formation of later-stage tumours".
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











